However, the expression of pro-tumorigenic genes including Ang4, VEGF, Wnt5a and MMP-10 was comparable in the LRRK2 KI and WT control groups (Figure 3I), suggesting that LRRK2 G2019S may promote tumor development primarily by promoting inflammation. The gene discussed is WNT5A; the disease is neoplasm.